Peter K Henke Selected Research

Thrombolytic Therapy

1/2015	Blood Accessibility to Fibrin in Venous Thrombosis is Thrombus Age-Dependent and Predicts Fibrinolytic Efficacy: An In Vivo Fibrin Molecular Imaging Study.
9/2003	A national and single institutional experience in the contemporary treatment of acute lower extremity ischemia.
11/2002	P-selectin inhibition enhances thrombus resolution and decreases vein wall fibrosis in a rat model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter K Henke Research Topics

Disease

58	Thrombosis (Thrombus) 11/2023 - 05/2002
49	Venous Thrombosis (Deep-Vein Thrombosis) 11/2023 - 11/2002
20	Abdominal Aortic Aneurysm 01/2023 - 02/2002
16	Inflammation (Inflammations) 01/2023 - 06/2003
14	Myocardial Infarction 11/2023 - 03/2003
14	Fibrosis (Cirrhosis) 01/2022 - 11/2002
12	Venous Thromboembolism 12/2022 - 09/2002
12	Aneurysm (Aneurysms) 04/2015 - 08/2004
11	Hemorrhage 01/2023 - 11/2005
11	Wounds and Injuries (Trauma) 01/2019 - 06/2005
8	Renal Insufficiency (Renal Failure) 01/2017 - 05/2002
8	Neoplasms (Cancer) 10/2012 - 05/2003
7	Stroke (Strokes) 11/2023 - 01/2004
7	Pathologic Constriction (Stenosis) 01/2023 - 01/2006
6	Heart Failure 01/2020 - 02/2004
5	Chronic Limb-Threatening Ischemia 11/2019 - 08/2013
5	Anemia 01/2018 - 12/2014
5	Peripheral Arterial Disease 01/2016 - 08/2011
4	Venous Insufficiency 01/2021 - 09/2005
4	Pneumonia (Pneumonitis) 01/2021 - 02/2007
4	Aortic Aneurysm (Aneurysm, Aortic) 01/2020 - 08/2004
4	Neutropenia 01/2017 - 05/2003
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2016 - 03/2003
4	Ischemia 03/2009 - 02/2002
3	Surgical Wound Infection 11/2023 - 11/2009
3	COVID-19 01/2023 - 01/2021
3	Leukemia 01/2023 - 01/2019
3	Pulmonary Embolism 01/2021 - 09/2002
3	Postthrombotic Syndrome 01/2021 - 02/2011
3	Vascular Diseases (Vascular Disease) 01/2020 - 02/2004
3	Diabetes Mellitus 01/2020 - 05/2002
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 05/2002
3	Hypertension (High Blood Pressure) 01/2017 - 12/2006
3	Pain (Aches) 06/2010 - 05/2002
3	Aortic Dissection 10/2006 - 10/2002
2	Transient Ischemic Attack 11/2023 - 02/2005
2	Atrial Fibrillation 11/2022 - 12/2020
2	Critical Illness (Critically Ill) 01/2021 - 01/2019
2	Hyperplasia 01/2021 - 04/2006

Drug/Important Bio-Agent (IBA)

18	P-SelectinIBA 01/2016 - 09/2002
16	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022 - 11/2002
15	CollagenIBA 11/2023 - 08/2003
15	Matrix Metalloproteinases (MMPs)IBA 01/2023 - 08/2004
12	AnticoagulantsIBA 11/2023 - 11/2002
10	Proteins (Proteins, Gene)FDA Link 03/2015 - 06/2003
9	EnzymesIBA 01/2023 - 11/2002
8	CytokinesIBA 01/2019 - 09/2002
8	Pancreatic Elastase (Elastase)IBA 11/2016 - 08/2004
6	fibrin fragment D (D-dimer)IBA 01/2021 - 12/2005
6	Histones (Histone)IBA 01/2020 - 04/2015
6	Plasminogen Activators (Plasminogen Activator)IBA 01/2015 - 10/2007
6	ImmunosorbentsIBA 09/2006 - 11/2002
5	Histone MethyltransferasesIBA 01/2023 - 01/2017
5	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2023 - 10/2007
5	Thromboplastin (Tissue Factor)IBA 01/2023 - 11/2002
5	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 09/2003
5	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018 - 06/2003
5	Plasminogen Activator Inhibitor 1IBA 10/2014 - 12/2010
4	LigandsIBA 01/2023 - 08/2005
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 02/2004
4	Toll-Like Receptor 9IBA 03/2020 - 01/2011
4	InterleukinsIBA 01/2018 - 08/2005
4	CreatinineIBA 06/2017 - 01/2007
4	E-SelectinIBA 01/2017 - 09/2002
4	Enoxaparin (Lovenox)FDA LinkGeneric 01/2017 - 02/2010
4	Fibrinolysin FDA Link 10/2012 - 10/2007
4	ChemokinesIBA 01/2009 - 09/2002
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 03/2015
3	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2023 - 09/2005
3	ElastinIBA 01/2023 - 11/2006
3	Phenobarbital (Luminal)FDA Link 01/2022 - 03/2008
3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 04/2006
3	Fibrinogen (Factor I)FDA Link 01/2021 - 03/2009
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2011
3	Lysine (L-Lysine)FDA Link 01/2020 - 01/2017
3	InterferonsIBA 01/2019 - 12/2010
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2014 - 05/2013
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 09/2013 - 07/2005
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2010 - 10/2007
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2007 - 04/2006
3	2- (4- chlorobenzyl)- 3- hydroxy- 7,8,9,10- tetrahydrobenzo(H)quinoline- 4- carboxylic acidIBA 03/2007 - 08/2005
2	Metalloproteases (Metalloproteinases)IBA 01/2023 - 01/2018
2	Peroxidase (Myeloperoxidase)IBA 01/2021 - 01/2015

Therapy/Procedure

29	Therapeutics 01/2023 - 05/2003
14	Surgical Amputation (Amputations) 11/2023 - 05/2002
13	Ligation 01/2022 - 11/2002
8	Vascular Surgical Procedures 01/2021 - 01/2004
6	Renal Dialysis (Hemodialysis) 01/2019 - 05/2002
6	Limb Salvage 12/2014 - 02/2004
5	Catheters 11/2023 - 02/2003
4	Chemoprevention 12/2022 - 05/2014
4	Length of Stay 11/2022 - 01/2004
4	Endovascular Procedures 11/2019 - 01/2006
3	Endovascular Aneurysm Repair 01/2021 - 04/2015
3	Carotid Endarterectomy 01/2021 - 02/2005
3	Blood Transfusion (Blood Transfusions) 01/2016 - 02/2007
3	Thrombolytic Therapy 01/2015 - 11/2002
3	Colectomy 10/2012 - 11/2005
2	Aftercare (After-Treatment) 01/2022 - 08/2003
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2021 - 11/2005